Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04864028
Other study ID # RBHP 2020 DUCLOS 3
Secondary ID 2020-A03311-38
Status Completed
Phase N/A
First received
Last updated
Start date May 25, 2021
Est. completion date June 29, 2023

Study information

Verified date July 2023
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The recent literature has highlighting the importance of the time of SB and the level of physical activity (PA) as predictors of metabolic cardio risks. Now, sedentary lifestyles are well recognized as one of the causes of mortality. As with physical activity, a dose-response relationship appears to exist: mortality would increase with time spent in sedentary behaviors. However, this relationship would not be linear: the more the daily sitting time increases, the more the consequences on mortality are important. It is now well demonstrated that time spent in sedentary adult behaviour finds primarily its origin in the work, characterized by prolonged and uninterrupted periods of sitting. Many strategies have been settled to break the prolonged sitting time. The most promising one seem to be the use of active workstations (standing, walking, cycling, stepping) because they reduce sedentary time at work and increase physical activity with positive effects on the global health. However inter variability in energy response have been identified during a sit to stand allocation with subject "savers" profile showing an increase in energy expenditure while others categorized as "non-savers" increased significantly their energy expenditure between sitting and standing position. As others active workstation strategies exist, this study aim to first, better characterize energy response to posture and activity allocation (15min sit-15min stand-15min sit-15min low intensity cycling), secondly to identify parameters that could explain different energy profile.


Description:

Subject will have an inclusion visit during a medical consultation where the eligibility criteria to participate to this study will be checked. During a second experimental visit, subjects will have to take a calibrated breakfast. Three hours after the breakfast, body composition will be assessed and energy expenditure and substrates oxidation will be measured with an indirect calorimetry device during 15min in a sitting position fallowed by 15min in standing position , 15min in a sitting position and 15min of low intensity cycling with a cycling desk. Then subjects will underwent physical capacity test : - 6min step test - Handgrip test - lower limb strength test Finally, subjects will be equipped with accelerometer and inclinometer device they will need to wore during 7 days.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date June 29, 2023
Est. primary completion date December 12, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria: - Healthy volunteer, male or female, between 18 and 61 years old - Body mass index > 18,5 kg/m2 and = 25 kg/m2 - Able to provide informed consent to research participation - Registered in the French social security system Exclusion Criteria: - Subject using a sit-to-stand office desk or a swiss ball - Contact jobs (face-to-face with people) - Pregnant or breastfeeding women - Medical or surgical history determined by principal investigator to be not compatible with the study - Subject with cardiorespiratory and/or osteo-articular disorders limiting their ability to perform physical tests or the use of active offices - Subject with type 1 or type 2 diabetes treated with insulin - Subject with progressive cardiovascular or neoplastic disease. - Subject with a major infection within 3 months of inclusion. - Subject with known neuromuscular pathology: myopathy, myasthenia, rhabdomyolysis, paraplegia, hemiplegia - Subject with chronic or acute inflammatory pathology 3 months prior to inclusion

Study Design


Related Conditions & MeSH terms


Intervention

Other:
physical activity
15min sitting, 15min standing, 15min sitting, 15 min low intensity cycling

Locations

Country Name City State
France CHU de Clermont-Ferrand Clermont-Ferrand

Sponsors (3)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand Laboratory AME2P UR3533, Université d'Auvergne

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary energy expenditure Using an indirect calorimetry device change in energy expenditure will be assed during the 1h posture /activity allocation (15min sitting, 15min standing, 15min sitting, 15 min low intensity cycling) change from baseline to the experimental visit (Day 1)
Secondary physical activity level (ActiGraph) using acceleometry device (ActiGraph Gt3x) during the 7 days following the experimental session
Secondary physical activity level (ActivPAL) using accelerometry (ActivPAL) during the 7 days following the experimental session
Secondary Body composition : fat mass and fat free mass body composition will be assessed by bioelectrical impedance device (TANITA MC-780MA) day 0
Secondary upper limb strength will be assessed with handgrip for upper limb muscle during the experimental session after energy expenditure assessment (Day 1)
Secondary aerobic fitness will be assessed with the Step Test 6 minutes during the experimental session after energy expenditure assessment (day 1)
Secondary lower limb strength will be assessed with isokinetic dynamometer during the experimental session after energy expenditure assessment (day1)
Secondary eating profile with DEBQ questionnaire (Dutch Eating Behavior Questionnaire) the questionnaire will identify with a scale (items to rank between never and always) three major factors influencing eating behavior "emotional , restrained and external eating". For all items score goes from 0 to 5pts and the lower score the better/healthier. during the experimental session before energy expenditure assessment (day 1)
Secondary eating profile with TFEQ questionnaire (Three-Factor Eating Questionnaire) the questionnaire will identify with a scale (items to rank between never and always) three major eating profiles (cognitive restraint, disinhibition, hunger). For Items 1 to 16 score goes from 4 to 1pts, from items 17-21 score goes from 1 to 4 pts. Global score is calculated the lower the healthier. during the experimental session before energy expenditure assessment (day 1)
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1